The surviving sepsis campaign guidelines: Should we follow?

Israel Medical Association Journal

Volumn 13, Issue 11, 2011, Pages 692-693

  Singer, Pierre ^a,b   Cohen, Jonathan D ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Activated protein C; Parenteral nutrition; Sepsis Campaign guidelines

Indexed keywords

ACTIVATED PROTEIN C; DROTRECOGIN; GLUCOSE; STEROID;

BLEEDING; BLOOD GLUCOSE MONITORING; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG COST; EDITORIAL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INFECTION RISK; LOW DRUG DOSE; MORTALITY; PARENTERAL NUTRITION; PRACTICE GUIDELINE; QUALITY CONTROL; RATING SCALE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; SUPERINFECTION; SURVIVAL RATE;

ADRENAL CORTEX HORMONES; AMERICAS; ANTI-INFECTIVE AGENTS; BLOOD GLUCOSE; EUROPE; GUIDELINE ADHERENCE; HUMANS; INFECTION CONTROL; INTERNATIONALITY; ISRAEL; PARENTERAL NUTRITION; PRACTICE GUIDELINES AS TOPIC; PROTEIN C; RECOMBINANT PROTEINS; SEPSIS; SOCIETIES, MEDICAL; SURVIVAL RATE;

EID: 80755176711     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Angus DC, Linde-Zwirble, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29: 1303-10.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993-2003. Crit Care Med 2007; 35: 1244-50.
3. Dreiher J, Almog Y, Sprung C, et al., for SEPSISISR Group. Intensive care admissions with sepsis. Temporal trends in patient characteristics and survival. Crit Care Med 2011. In press.
4. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. 2008. Crit Care Med 2004; 32: 858-73.
5. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17-60.
6. Carney DE, Matsushima K, Frankel HL. Treatment of sepsis in the surgical intensive care unit. IMAJ Isr Med Assoc J 2011; 13: 694-9.
7. Moran JL, Graham PL, Rockliff S, Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesion meta-analytic perspective. Crit Care 2010; 14: R134.
8. Kalil AC, Sun J. Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies. Intensive Care Med 2011; 37: 420-9.
9. Sprung CL, Brezis M, Goodman S, Weiss YG. Corticosteroid therapy for patients in septic shock: some progress in a difficult decision. Crit Care Med 2011; 39: 571-4.
10. McClave SA, Martindale RG, Vanek V, et al: Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of critical care medicine (SCMCM) and American society for parenteral and enteral nutrition (ASPEN). JPEN 2009; 33: 277-316.
11. Singer P, Berger MM, Van den Berghe G, et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr 2009; 28: 387-400.
12. Bernard GR, Vincent JL, Laterre PF, et al. Recombitant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
13. Marti-Carvajal AJ, Sola I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev 2011; 4: CD004388.
14. Sadaka F, O'Brien J, Migneron M, Stortz J, Vanston A, Taylor RW. Activated protein C in septic shock: a propensity-matched analysis. Crit Care 2011; 15: R89.
15. Ferrer R, Artigas A, Levy MM, et al., for the Edusepsis Study Group. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299: 2294-303.
16. Pestana D, Espinosa E, Sanguesa-Molina JR, et al., for the REASEP Sepsis Study Group. Compliance with a sepsis bundle and its effect on intensive care unit mortality in surgical septic shock patients. J Trauma 2010; 69: 1282-7.
17. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36: 222-31.